References
- Talty, A., Morris, R. & Deighan, C. Home-based self-management multimodal cancer interventions & cardiotoxicity: a scoping review. Cardio-Oncology, 12 10 (2024). https://doi.org/10.1186/s40959-024-00204-6
- Caroline Schneider, Annika Dierks, Manuela Rabaglio, et al. Timing of cardio-oncological rehabilitation and cardiorespiratory fitness in patients receiving cardiotoxic chemotherapy: a longitudinal observational study, Swiss Medical Weekly, 154, 6, (3588), (2024). https://doi.org/10.57187/s.3588
- Schneider C, Dierks A, Rabaglio M, Campbell KL, Wilhelm M, Eser P. Timing of cardio-oncological rehabilitation and cardiorespiratory fitness in patients receiving cardiotoxic chemotherapy: a longitudinal observational study. Swiss Med Wkly. 2024 Jun 17;154:3588. doi: 10.57187/s.3588.
- Morelli MB, Bongiovanni C, Da Pra S, et al. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection. Front Cardiovasc Med. 2022 Apr 15;9:847012. doi: 10.3389/fcvm.2022.847012.
- Elad, B.; Habib, M.; Caspi, O. Cardio-Oncology Rehabilitation—Present and Future Perspectives. Life 2022, 12, 1006. https://doi.org/10.3390/life12071006
- Irma Bisceglia, Elio Venturini, Maria Laura Canale, et al. Cardio-oncology rehabilitation: are we ready?, European Heart Journal Supplements, Volume 26, Issue Supplement_2, April 2024, Pages ii252–ii263, https://doi.org/10.1093/eurheartjsupp/suae030
- Meijers WC, de Boer RA. Common risk factors for heart failure and cancer. Cardiovasc Res. 2019 Apr 15;115(5):844-853. doi: 10.1093/cvr/cvz035.
- de Boer RA, Meijers WC, van der Meer P, van Veldhuisen DJ. Cancer and heart disease: associations and relations. Eur J Heart Fail. 2019 Dec;21(12):1515-1525. doi: 10.1002/ejhf.1539.
- Bertero E, Canepa M, Maack C, Ameri P. Linking Heart Failure to Cancer: Background Evidence and Research Perspectives. Circulation. 2018 Aug 14;138(7):735-742. doi: 10.1161/CIRCULATIONAHA.118.033603.
- Kerrigan DJ, Reddy M, Walker EM, et al. Cardiac Rehabilitation Improves Fitness in Patients With Subclinical Markers of Cardiotoxicity While Receiving Chemotherapy: A RANDOMIZED CONTROLLED STUDY. J Cardiopulm Rehabil Prev. 2023 Mar 1;43(2):129-134. doi: 10.1097/HCR.0000000000000719.
- Li DL, Wang ZV, Ding G, et al. Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification. Circulation. 2016 Apr 26;133(17):1668-87. doi: 10.1161/CIRCULATIONAHA.115.017443.
- Fedele C, Riccio G, Malara AE, D’Alessio G, De Lorenzo C. Mechanisms of cardiotoxicity associated with ErbB2 inhibitors. Breast Cancer Res Treat. 2012 Jul;134(2):595-602. doi: 10.1007/s10549-012-2103-8.
- Fuller SJ, Sivarajah K, Sugden PH. ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium. J Mol Cell Cardiol. 2008 May;44(5):831-54. doi: 10.1016/j.yjmcc.2008.02.278.
- Gronek P, Wielinski D, Cyganski P, et al. A Review of Exercise as Medicine in Cardiovascular Disease: Pathology and Mechanism. Aging Dis. 2020 Mar 9;11(2):327-340. doi: 10.14336/AD.2019.0516.
- Powers SK, Deminice R, Ozdemir M, et al. Exercise-induced oxidative stress: Friend or foe? J Sport Health Sci . 2020 Sep; 9 (5) : 415 - 425 . doi : 10.1016/j.jshs.2020.04.001.
- Hollings M, Gordon N, Redfern J, Thomas L, Singleton A, et al. Characteristics and Outcomes of Cardiac Rehabilitation Patients With and Without Cancer: Insights From Western Sydney. Heart Lung Circ. 2024 May;33(5):730-737. doi: 10.1016/j.hlc.2023.11.017.
- Díaz-Balboa E, Peña-Gil C, Rodríguez-Romero B, et al. Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast cancer chemotherapy: The ONCORE randomized controlled trial. Prog Cardiovasc Dis. 2024 Jul-Aug;85:74-81. doi: 10.1016/j.pcad.2024.02.002.
- Amin AM, Khlidj Y, Abuelazm M, et al.The efficacy and safety of exercise regimens to mitigate chemotherapy cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials. Cardio-oncology. 2024 Feb 23;10(1):10. doi: 10.1186/s40959-024-00208-2.
- Jones LW, Eves ND, Mackey JR, Peddle CJ, Haykowsky M, Joy AA, et al. Systemic infammation, cardiorespiratory ftness, and quality of life in patients with advanced non-small cell lung cancer. J Thorac Oncol. 2008;3(2):194–5. https://doi.org/10.1097/JTO.0b013e318160f36b.
- Kwon I. Protective effects of endurance exercise on skeletal muscle remodeling against doxorubicin-induced myotoxicity in mice. Phys Act Nutr. 2020 Jun 30;24(2):11-21. doi: 10.20463/pan.2020.0010.
- Schmielau J, Rick O, Reuss-Borst M, et al. Rehabilitation of Cancer Survivors with Long-Term Toxicities. Oncol Res Treat. 2017;40(12):764-771. doi: 10.1159/000485187.
- Gonella F, Massucco P, Perotti S, et. al. Telemedicine prehabilitation as a result of COVID-19: disruptive technological solutions. Br J Surg. 2021 Jun 22;108(6):e215-e216. doi: 10.1093/bjs/znab066.
- Ariza-Garcia A, Lozano-Lozano M, Galiano-Castillo N, et al. A Web-Based Exercise System (e-CuidateChemo) to Counter the Side Effects of Chemotherapy in Patients With Breast Cancer: Randomized Controlled Trial. J Med Internet Res. 2019 Jul 24;21(7):e14418. doi: 10.2196/14418.